LEADERSHIP TEAM
OxThera is built on a highly-experienced and committed team and strong network in oxaluria research, rare disease drug development and anaerobic bacterial manufacturing.
Leadership Team
Elisabeth Lindner
Chief Operating Officer
Mats-Olof Wallin
Chief Financial Officer
© OxThera. All Rights Reserved
Trademarks: The following trademarks are owned and protected by OxThera and should not be misused or referred to incorrectly: OXTHERA, OXABACT, OXAZYME.
Stay in Touch
Email: info.oxthera@oxthera.com
Contact Us
Elisabeth Lindner, Chief Operating Officer
Born 1956. COO 2017-2020, Strategic Adviser 2020-2021, COO 2021-
Education: MSc in Biochemical Engineering from the Royal
Institute of Technology. MBA in Business Management from
Uppsala University.
Other current assignments: Member of the board of directors
of BioSource Europe AB.
Previous assignments (last five years): Member of the board
of directors of Cobra Biologics Holding AB and BioInvent International
Aktiebolag publ.
Shareholding in the Company: Elisabeth Lindner holds
no shares or options in the Company.
Mats-Olof Wallin, Chief Financial Officer
Born 1951. Deputy CEO since 2020 and CFO since 2020.
Education: BSc, Uppsala University
Other current assignments: Deputy board member and CEO
of OxThera Intellectual Property AB. Chairman of the board of
directors and CEO of Mowin Konsult AB.
Previous assignments (last five years): CFO of Karo Pharma AB
and Sobi AB.
Shareholding in the Company: Mats-Olof Wallin holds no
shares or options in the Company.